New target therapies for patients with neuroendocrine tumors of the pancreas (Journal article)

Baltogiannis, G./ Katsios, C./ Roukos, D. H.

Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Antineoplastic Agents/therapeutic use,Humans,Indoles/*therapeutic use,Neuroendocrine Tumors/*drug therapy/pathology,Pancreatic Neoplasms/*drug therapy/pathology,Pyrroles/*therapeutic use,Sirolimus/*analogs & derivatives/therapeutic use,Treatment Outcome,United States,United States Food and Drug Administration
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/19758
ISSN: 1747-4132
Link: http://www.ncbi.nlm.nih.gov/pubmed/21910571
http://www.expert-reviews.com/doi/pdfplus/10.1586/egh.11.55
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Baltogiannis-2011-New target therapies.pdf650.1 kBAdobe PDFView/Open    Request a copy


 Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/19758
  This item is a favorite for 0 people.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.